ALB-EXOSC9 Fusion FISH Probe
The ALB-EXOSC9 Fusion FISH Probe is used to confirm a fusion of the ALB and EXOSC9 genes. The fusion of the ALB and EXOSC9 genes has been associated with Kidney Renal Papillary Cell Carcinoma, and Liver Hepatocellular Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ALB-EXOSC9-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ALB-EXOSC9-20-AQAQ | 20 (40 μL) | 200 μL |
|
ALB Gene Summary
This gene encodes the most abundant protein in human blood. This protein functions in the regulation of blood plasma colloid osmotic pressure and acts as a carrier protein for a wide range of endogenous molecules including hormones, fatty acids, and metabolites, as well as exogenous drugs. Additionally, this protein exhibits an esterase-like activity with broad substrate specificity. The encoded preproprotein is proteolytically processed to generate the mature protein. A peptide derived from this protein, EPI-X4, is an endogenous inhibitor of the CXCR4 chemokine receptor. [provided by RefSeq, Jul 2016]
Gene Name: Albumin
Chromosome: CHR4: 74269971 -74287129
Locus: 4q13.3
EXOSC9 Gene Summary
This gene encodes a component of the human exosome, a exoribonuclease complex which processes and degrades RNA in the nucleus and cytoplasm. This component may play a role in mRNA degradation and the polymyositis/scleroderma autoantigen complex. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
Gene Name: Exosome Component 9
Chromosome: CHR4: 122722471 -122738176
Locus: 4q27
Gene Diseases
The ALB EXOSC9 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Kidney Renal Papillary Cell Carcinoma |
| Liver Hepatocellular Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|